Supplementary materials and methods

Examination of human MUC1 expression in mouse brain by Western blot analysis
Isolated mouse brains were kept on ice and homogenised immediately after adding ice-cold RIPA lysis buffer (150 mM NaCl, 0.1 %Triton X-100, 0.5 % sodium deoxycholate, 0.1 % SDS, 50 mM Tris-HCl, pH 8) containing protease inhibitor using an electric homogeniser. After 30 min -1 h incubation, homogenates were centrifuged at 17949 x g for 30 min and the supernatants were collected. Human breast cancer cells, MCF-7 (ATCC ® , HTB-22 TM ), are known to express high level of MUC1 and were used as a positive control. Cells were cultured in DMEM medium (Life Technologies, UK) supplemented with 10% FBS, 50 U/ml penicillin, 50 μg/ml streptomycin and 1 % L-glutamine in a T75 flask at 37 °C in a 5 % CO 2 incubator. When reaching 70-80% confluency, cells were rinsed twice with ice-cold PBS, incubated with 500 µl RIPA lysis buffer containing protease inhibitor and scrapped out. Cell proteins were collected after centrifugation as described. The protein concentrations from brain and cell samples were determined by BCA assay. Proteins (30 μg) from each sample was resolved in 8 % SDS-PAGE gels and transferred to Hybond ECL nitrocellulose membranes (GE Healthcare, UK). The membrane was blocked in 3% bovine serum albumin (Sigma-Aldrich, UK) at room temperature for 1 h, incubated with humanised anti-human MUC1 antibody (hCTM01 IgG, UCB Celltech, UK) at 10 μg/ml overnight on ice and incubated with the secondary antibody, horseradish peroxidase linked anti-human antibody (Cell Signalling Technology, USA) at 1:1000 dilution for 2 h at room temperature. Protein bands were detected using chemiluminescent kits (Immun-StarTM Chemiluminescent Kit, BioRad, UK) and imaged and quantitatively analysed using ChemiDoc MP imaging system and Image Lab software (BioRad, UK). Fab' immediately after radio-labeling reaction and quenching by EDTA, prior to injection, and radiolabelling stability after an incubation in PBS or 50 % serum (serum:PBS, 1:1) at 37 °C for 24 h. 
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